Cite
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study.
MLA
Iaffaldano, Pietro, et al. “Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study.” PloS One, vol. 7, no. 4, 2012, p. e35843. EBSCOhost, https://doi.org/10.1371/journal.pone.0035843.
APA
Iaffaldano, P., Viterbo, R. G., Paolicelli, D., Lucchese, G., Portaccio, E., Goretti, B., Direnzo, V., D’Onghia, M., Zoccolella, S., Amato, M. P., & Trojano, M. (2012). Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PloS One, 7(4), e35843. https://doi.org/10.1371/journal.pone.0035843
Chicago
Iaffaldano, Pietro, Rosa Gemma Viterbo, Damiano Paolicelli, Guglielmo Lucchese, Emilio Portaccio, Benedetta Goretti, Vita Direnzo, et al. 2012. “Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study.” PloS One 7 (4): e35843. doi:10.1371/journal.pone.0035843.